Analysis

Stakes High For J&J At Start Of Latest Baby Powder Trial

Law360, New York (February 8, 2017, 10:27 PM EST) -- After last year's trio of multimillion-dollar verdicts against Johnson & Johnson over claims that its talc-based baby powder causes ovarian cancer, attorneys will be watching the latest trial, set to kick off Thursday morning, to see if the fourth time will be a charm for the company.

The stakes are high for J&J, which racked up nearly $200 million in losses in Missouri state court last year as it faces more than 1,000 such cases in the state, plus centralized litigation in California and New Jersey. The pharmaceutical giant will have another crack at convincing jurors that the science doesn't support...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!